Woodward Other Income (Expense) decreased by 6.8% to $18.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 27.2%, from $24.80M to $18.06M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 23.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.36M | $6.68M | $10.67M | $4.89M | $3.25M | $7.88M | $8.39M | $12.04M | $13.00M | $16.86M | $20.64M | $14.38M | $14.44M | $17.71M | $23.09M | $24.80M | $17.86M | $18.26M | $19.37M | $18.06M |
| QoQ Change | — | -35.5% | +59.7% | -54.2% | -33.5% | +142.3% | +6.5% | +43.5% | +8.0% | +29.7% | +22.4% | -30.3% | +0.4% | +22.6% | +30.4% | +7.4% | -28.0% | +2.2% | +6.1% | -6.8% |
| YoY Change | — | — | — | — | -68.6% | +17.9% | -21.4% | +146.4% | +299.8% | +114.0% | +146.0% | +19.5% | +11.1% | +5.0% | +11.9% | +72.4% | +23.7% | +3.1% | -16.1% | -27.2% |